CARB labeling regs
This article was originally published in The Rose Sheet
Executive Summary
Changes to product dating requirements under California Consumer Products Regulation are effective this month, state Air Resources Board reminds companies in recent advisory. Manufacturers must display the actual date of manufacture, regulation's standard date code or firm's own code on each consumer product container. Manufacturers using their own codes must file explanations of the code, to be received by CARB on or before Jan. 31 annually, with the first explanation due this month. Explanations of modified non-standard codes must be received by CARB before any products with such a code are sold or supplied in the state. Additionally, all products manufactured on or after Jan. 1, 2006 must display dates and date codes that are "readily observable" without removing any product packaging. Date and date codes on the bottom of a container are allowed. CARB passed amendments to the consumer product reg relating to code dating in 2004 (1"The Rose Sheet" June 28, 2004, In Brief)...
You may also be interested in...
CARB
California Air Resources Board unanimously approves amendments to volatile organic compound standards in agency's consumer products regulation, including changes to code dating practices, modifications to "deodorant" and "personal body spray" definitions and a two-tiered VOC limit for shave gels during a June 24 board meeting in El Monte, Calif. CARB outlined the proposed amendments in a statement of reason issued May 7 (1"The Rose Sheet" May 17, 2004, p. 8). The Cosmetic, Toiletry and Fragrance Association says it will assist its members in meeting the 7% VOC emission standard for shaving gels by 2006, and will "make every effort" to achieve the 4% standard by 2009, CTFA VP-Legal & General Counsel Thomas Donegan said. However, the association expects CARB will conduct a technical review of the feasibility of the 4% standard by the end of 2008, Donegan added...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.